Clinical Trial Update: A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Venglustat tablets for neuropathic and abdominal pain in people with Fabry disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Venglustat (venglustat)

Snippet

Sponsor: Sanofi | Conditions: Fabry Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING